Skip to search formSkip to main contentSkip to account menu

Eribaxaban

An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Eribaxaban is no longer on the market.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Regulators and industry tackle dose-finding issues
Industry experts ask for regulatory guidelines and assurance on the value of well-designed Phase IIb dose-finding studies to help… 
Review
2009
Review
2009
Factor Xa inhibitors
Summary Oral factor Xa (FXa) inhibitors are a promising alternative to current anticoagulants. This paper reviews the latest… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)